Gossamer Bio
GOSS
122 hedge funds and large institutions have $513M invested in Gossamer Bio in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 22 closing their positions.
223% more call options, than puts
Call options by funds: $5.96M | Put options by funds: $1.85M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
52% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 31
2% less funds holding
Funds holding: 125 → 122 (-3)
3.3% less ownership
Funds ownership: 73.24% → 69.95% (-3.3%)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
25% less capital invested
Capital invested by funds: $684M → $513M (-$171M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$14.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$6.81M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$6.52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.38M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$43.6M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$22M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$21.3M |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$8.69M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.26M |
GOSS Hedge Fund Activity: Q4 2020 in Review
122 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q4 2020, worth a combined $513M — down 25% from $684M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of GOSS and 19 opened new positions — a net loss of 3 holders — while 31 trimmed existing stakes and 47 added.
The largest buyer was Federated Hermes, adding an estimated $14.2M. The largest seller was Capital International Investors, cutting an estimated $43.6M.
- 122 institutional investors held Gossamer Bio (GOSS) as of Q4 2020, down from 125 in Q3 2020.
- Funds reported $513M of Gossamer Bio stock for Q4 2020, down 25% quarter-over-quarter.
- 19 funds opened new Gossamer Bio positions in Q4 2020 and 22 closed out, a net change of -3 holders.
- The largest Gossamer Bio buyer in Q4 2020 was Federated Hermes, an estimated $14.2M added.
- The largest Gossamer Bio seller in Q4 2020 was Capital International Investors, an estimated $43.6M sold.
Based on aggregated 13F filings for Q4 2020.